
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter D - Drugs for Human Use
#### PART 312 - INVESTIGATIONAL NEW DRUG APPLICATION
##### Subpart I - Expanded Access to Investigational Drugs for Treatment Use
###### ยง 312.305 Requirements for all expanded access uses.
####### Protocols.

(2)With the following exceptions, expanded access use under a protocol submitted under an existing IND may begin as described in ยง 312.30(a).

(i) Expanded access use under the emergency procedures described in ยง 312.310(d) may begin when the use is authorized by the FDA reviewing official.

(ii) Expanded access use under ยง 312.320 may begin 30 days after FDA receives the protocol or upon earlier notification by FDA that use may begin.
